21 CFR Part 11 is a regulation issued by the U.S. Food and Drug Administration (FDA) that defines the requirements for electronic records and electronic signatures in FDA-regulated industries such as pharmaceuticals, biotechnology, and medical devices. It ensures that digital records are trustworthy, reliable, and equivalent to paper records, helping organizations maintain data integrity, security, and traceability in electronic systems.
Life sciences companies rely on electronic records for research, development, and regulatory submissions. FDA 21 CFR Part 11 sets standards for how these records must be stored, accessed, and signed to prevent unauthorized modifications, loss, or non-compliance. Failure to comply can lead to regulatory penalties, data breaches, and setbacks in product approvals.
To comply with FDA 21 CFR Part 11, electronic record-keeping systems must include:
Labguru provides a validated electronic lab notebook (ELN), LIMS, and inventory management system designed to support FDA 21 CFR Part 11 compliance. With Labguru, you can:
By using Labguru, you can streamline compliance, enhance data integrity, and reduce the administrative burden of maintaining FDA-compliant digital records.